HSAQ
HSAQ P/E Ratio
P/E Ratio as of Nov 10, 2026: -5.73
Average-5.73
Median-5.71
Minimum-6.09
Maximum-5.45
-5.73
0.22 (3.70%)past month
The P/E ratio for HSAQ is -5.73 as of Nov 10, 2026. This represents a increase of 56.56% compared to its 12-month average P/E ratio of -3.66. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Health Sciences Acquisitions Corporation 2 P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Health Sciences Acquisitions Corporation 2’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Health Sciences Acquisitions Corporation 2 to industry peers.
Health Sciences Acquisitions Corporation 2 P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Health Sciences Acquisitions Corporation 2’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Health Sciences Acquisitions Corporation 2 to industry peers.
HSAQ P/E Ratio Insights
See Health Sciences Acquisitions Corporation 2’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in HSAQ
Order type
Buy in
Order amount
Est. shares
0 shares
HSAQ P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Nov 2, 2026 | $5.69 | -5.69 |
| Oct 1, 2026 | $6.35 | -6.35 |
| Sep 1, 2026 | $4.90 | -4.90 |
| Aug 3, 2026 | $4.12 | -3.65 |
| Jul 1, 2026 | $4.30 | -3.81 |
| Jun 1, 2026 | $3.83 | -3.40 |
| May 1, 2026 | $3.97 | -3.08 |
| Apr 1, 2026 | $4.34 | -3.37 |
| Mar 2, 2026 | $4.38 | -2.41 |
| Feb 2, 2026 | $4.02 | -2.21 |
| Jan 2, 2026 | $4.31 | -2.37 |
HSAQ End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -5.73 | +151.32% |
| 2025 | -2.28 | -9.16% |
| 2024 | -2.51 | -67.02% |
| 2023 | -7.61 | -91.49% |
| 2022 | -89.43 | -83.59% |
| 2021 | -544.86 | — |
FAQs About Health Sciences Acquisitions Corporation 2 (HSAQ) P/E ratio
The latest P/E ratio of HSAQ is -5.73, as of Nov 10, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Health Sciences Acquisitions Corporation 2’s last 12-month average P/E ratio is -3.66, compared to its current P/E ratio of -5.73. This reflects a increase of 56.56%.
Health Sciences Acquisitions Corporation 2’s current P/E ratio of -5.73 is higher than its last 12-month average P/E of -3.66. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Health Sciences Acquisitions Corporation 2’s average P/E ratio over the last 3 years is -3.41. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Health Sciences Acquisitions Corporation 2’s average P/E ratio over the last 5 years is -68.43. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
HSAQ P/E Ratio Insights
See Health Sciences Acquisitions Corporation 2’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in HSAQ
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.